novo - Search News

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Novo’s Weight Loss Drugs Removed from FDA Shortage List

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and diabetes drugs,

NBC New York · 2d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

STAT · 2d

Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.

NVO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Novo Nordisk A/S Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / February 23, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

2don MSN

Why Novo Nordisk Stock Popped on Friday

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...

1don MSN

Lilly, Novo dominance to continue as TD Cowen lifts 2030 GLP-1 sales forecast by 38%

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

FiercePharma2d

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

10don MSN

Why Novo Nordisk Stock Keeps Going Down

Novo Nordisk ( NVO -1.22%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...

Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently

Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...

European Shares Notch Ninth Weekly Gain; Novo Nordisk Jumps

European stocks rose for a ninth straight week, boosted by shares of chemicals companies and Novo Nordisk A/S gains. Traders are also looking ahead to German elections on Sunday.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Related topics